Breakpoint Therapeutics

Provider anti-cancer drug based on DNA repair mechanism

placeHamburg, Hamburg, Germany calendar_todayFounded 2019 groups5 employees language breakpointtx.com

Registered entities

Investor mix

2 investors on record; lead investors include Medicxi.

Investor typeCountShare
Venture capital2100%
Coming soon